Synergy of Atopy and Airway Dysbiosis Promotes IL-5 Expression and
Asthma Persistence in Children
Abstract
Background: Recent studies increasingly suggest that airway microbiome
plays a critical role in respiratory health and disease, including the
potential influence on the development and persistence of asthma in
children. This study aims to evaluate the clinical, immunological, and
microbiological factors contributing to the persistence of asthma from
preschool to school age. Methods: 183 children aged 4-8 years with
chronic rhinosinusitis were enrolled in the study, including 82 children
(62%) with asthma. Nasopharynx swabs were collected for microbiome
analysis using next-generation sequencing methods, and nasal mucosa
samples were taken to analyze mRNA expressions of predefined cytokines
and innate lymphoid cells (ILCs). Out of the initial cohort, 117
children, including 74 with asthma, remained under observation for the
next five years to assess asthma persistence Results: After 5 years
asthma persisted in 23% (17 of 74) of patients. A multivariate model of
logistic regression analysis revealed that asthma persistence was
independently associated with atopy (OR=8.5, 95%CI: 1.7-43) and reduced
biodiversity in the upper airway microbiome (OR=6.0, 95%CI: 1.7-22).
Additionally, higher nasal expression of TSLP which correlated with IL-5
was observed in children with reduced biodiversity. In children with
both atopy and reduced biodiversity higher nasal expression of IL-5 was
detected, with the highest risk of persistent asthma. Conclusion:
Reduced biodiversity concomitant with atopy is associated with increased
risk of asthma persistence. This interaction is associated with higher
nasal expression of IL-5. These findings identify new potential targets
for the prevention of persistent asthma in children